Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
21 October 2024 | Story Litha Banjatwa | Photo Supplied
Matriculant of the year 2024
This year’s winner, Jayden Leech (centre), deputy head boy and hockey captain at Grey College.

For more than four decades, the University of the Free State (UFS) has used its annual Matriculant of the Year competition to attract the country’s top matriculants. This prestigious award recognises and celebrates the exceptional achievements of South African high school students who excel in academics, sports, culture, and leadership.

This year’s winner, Jayden Leech, deputy head boy and hockey captain at Grey College, stands out not only for his academic average of 90% but also for his sporting achievements. He has represented South Africa in karate and has been a member of the Free State Hockey and Waterpolo teams for the past three years. Jayden has been selected to pursue a medical degree.

The competition is closely aligned with the UFS’s Vision 130, which envisions a future where academic excellence, innovation, and societal impact are prioritised. “By recognising academic success, creativity, resilience, and leadership potential, the university aims to attract the brightest minds to join its community. This competition serves as a platform to identify and nurture future leaders who will help address South Africa's pressing challenges,” says Nomonde Mbadi, Director of Student Recruitment Services.

This year, the competition attracted 60 applicants, with a strong representation of women - 43 women and 17 men. The Free State province led with 28 entries, followed by North West, KwaZulu-Natal, and Gauteng. Popular fields of study among applicants included Medicine (MBChB), Accounting, Engineering, and Law. While the overall academic average of all entries was an impressive 81%, the top 14 finalists achieved an outstanding average of 85%.

Through a series of interviews and group activities, candidates were assessed on their critical thinking, communication skills, and ability to collaborate effectively. The Matriculant of the Year is ultimately selected for their overall balance, leadership potential, and capacity to serve as an ambassador for the UFS.

The Matriculant of the Year competition reflects the UFS’s commitment to fostering a diverse, inclusive, and equitable learning environment, aligned with the university’s values of social justice and sustainability. “By aligning this competition with Vision 130, we reaffirm the UFS’s dedication to transforming lives, creating opportunities, and shaping the next generation of leaders who will drive societal and economic progress,’’ adds Mbadi. 

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept